All filters
Abstracts
Examining differences in syndemic factors by gender and sexual orientation among women, straight men, and gay, bisexual, and other men who have sex with men living with HIV in British Columbia, Canada
K. Closson
Reviews in Antiviral Therapy & Infectious Diseases 1, 2020
Presented at:
International Workshop on HIV & Women 2020
Abstracts
CD4:CD8 ratio normalization among treatment naive women
A. Zhabokritsky
Reviews in Antiviral Therapy & Infectious Diseases 1, 2020
Presented at:
International Workshop on HIV & Women 2020
Abstracts
Attitudes towards health, sexual intimacy, and child-bearing among women living with HIV in 24 countries
C. Okoli
Reviews in Antiviral Therapy & Infectious Diseases 1, 2020
Presented at:
International Workshop on HIV & Women 2020
Abstracts
Differences by gender and sexual orientation in treatment satisfaction and aspirations among persons living with HIV
C. Okoli
Reviews in Antiviral Therapy & Infectious Diseases 1, 2020
Presented at:
International Workshop on HIV & Women 2020
Abstracts
Gender, equality, and empowered decision making in HIV care
C. Okoli
Reviews in Antiviral Therapy & Infectious Diseases 1, 2020
Presented at:
International Workshop on HIV & Women 2020
Abstracts
Impact of microbial exposures on HPV immune titers and infection among HPV-vaccinated women living with HIV
E. McClymont
Reviews in Antiviral Therapy & Infectious Diseases 1, 2020
Presented at:
International Workshop on HIV & Women 2020
Abstracts
Women race, age and regional US & non-US subgroup analysis of dolutegravir (DTG) and non-integrase inhibitor treatment (non-INSTI) regimens in naïve randomized clinical trials at Week 48.
R. Quercia
Reviews in Antiviral Therapy & Infectious Diseases 1, 2020
Presented at:
International Workshop on HIV & Women 2020
Abstracts
ATLAS and FLAIR: efficacy, pharmacokinetics and reasons for satisfaction in women with cabotegravir & rilpivirine long acting regimen at week 48
R. Quercia
Reviews in Antiviral Therapy & Infectious Diseases 1, 2020
Presented at:
International Workshop on HIV & Women 2020
Abstracts
Dolutegravir-containing ART does not reduce etonogestrel implant concentrations
R. Patel
Reviews in Antiviral Therapy & Infectious Diseases 1, 2020
Presented at:
International Workshop on HIV & Women 2020
Abstracts
Cabotegravir: Assessment of reproductive and developmental toxicity in animal studies1
M. Ziejewski
Reviews in Antiviral Therapy & Infectious Diseases 1, 2020
Presented at:
International Workshop on HIV & Women 2020
Abstracts
Achieving the third 95: Keeping adolescents living with HIV virally suppressed in rural Nigeria in test and treat era using Continuous Quality Improvement Model of Peer Counseling & Support Group
S. Usman
Reviews in Antiviral Therapy & Infectious Diseases 1, 2020
Presented at:
International Workshop on HIV & Women 2020
Abstracts
Cabotegravir pharmacokinetic tail in pregnancy and neonatal outcomes
Reviews in Antiviral Therapy & Infectious Diseases 1, 2020
Presented at:
International Workshop on HIV & Women 2020
Abstracts
Timing of HIV diagnosis in HIV-positive pregnant women giving birth in a high prevalence Russian region
R. Sconza
Reviews in Antiviral Therapy & Infectious Diseases 1, 2020
Presented at:
International Workshop on HIV & Women 2020
Abstracts
Mode of birth among women living with HIV: A population-based retrospective cohort study
E. Shoemaker
Reviews in Antiviral Therapy & Infectious Diseases 1, 2020
Presented at:
International Workshop on HIV & Women 2020
Abstracts
Prevalence of polypharmacy and medication use contraindicated during pregnancy among a cohort of women living with HIV who are of childbearing age, 2016-2017.
W. Short
Reviews in Antiviral Therapy & Infectious Diseases 1, 2020
Presented at:
International Workshop on HIV & Women 2020
Abstracts
Clinical trial simulation to improve HIV pre-exposure prophylaxis dosing in pregnancy
A. Chaturvedula
Reviews in Antiviral Therapy & Infectious Diseases 1, 2020
Presented at:
International Workshop on HIV & Women 2020
Abstracts
Why Sex make a difference in HIV clinical course? A bioinformatics analysis of differential expressed gene in male and female with HIV disease
K. Suwanwongse
Reviews in Antiviral Therapy & Infectious Diseases 1, 2020
Presented at:
International Workshop on HIV & Women 2020
Abstracts
Disparities in PrEP uptake and adherence: implementation of routine adherence monitoring in Philadelphia PrEP clinic
G. Daughtridge
Reviews in Antiviral Therapy & Infectious Diseases 1, 2020
Presented at:
International Workshop on HIV & Women 2020
Abstracts
HIV transmission patterns among people who inject drugs in the United States
S. Sami
Reviews in Antiviral Therapy & Infectious Diseases 1, 2020
Presented at:
International Workshop on HIV & Women 2020
Abstracts
HIV/AIDS prevention interventions for black women in the US: A systematic review
A. Sophus
Reviews in Antiviral Therapy & Infectious Diseases 1, 2020
Presented at:
International Workshop on HIV & Women 2020
Abstracts
Gender based barriers affecting partner notification among HIV positive clients assessing care and treatment services in South East, Nigeria
A. Eze
Reviews in Antiviral Therapy & Infectious Diseases 1, 2020
Presented at:
International Workshop on HIV & Women 2020
Abstracts
Relation between disease knowledge, antiretroviral adherence and viral outcomes in women with HIV in Chile.
C. Cortes
Reviews in Antiviral Therapy & Infectious Diseases 1, 2020
Presented at:
International Workshop on HIV & Women 2020
Abstracts
U=U among women – are we there yet?
A. Wroblewka
Reviews in Antiviral Therapy & Infectious Diseases 1, 2020
Presented at:
International Workshop on HIV & Women 2020
Abstracts
Gender-based vulnerability in women who inject drugs
J. Valencia
Reviews in Antiviral Therapy & Infectious Diseases 1, 2020
Presented at:
International Workshop on HIV & Women 2020